Further investigations with [99mTc]Tc-EDDA/HYNIC-iPSMA demonstrated high detection rates for PSMA positive lesions, especially in the setting of biochemically recurrence of prostate cancer but a lower sensitivity compared with PET PSMA tracer [4, 19]. This evidence concerns the gene FOLH1 and Familial prostate cancer.